TrialAddiction (Abingdon, England)2026

Secondary analysis of a combined harm-reduction treatment and extended-release naltrexone randomized clinical trial for alcohol use disorder: Differences across race, ethnicity and sex assigned at birth.

Silvi C Goldstein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.